Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Shandong Bailong Chuangyuan Bio-Tech Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 35.17%.
SHSE:605016'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 21.46 Med: 25.31 Max: 33.51
Current: 33.51
During the past 10 years, Shandong Bailong Chuangyuan Bio-Tech Co's highest ROC (Joel Greenblatt) % was 33.51%. The lowest was 21.46%. And the median was 25.31%.
SHSE:605016's ROC (Joel Greenblatt) % is ranked better than 82.31% of 1979
companies
in the Consumer Packaged Goods industry
Industry Median: 12.05
vs SHSE:605016: 33.51
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Bailong Chuangyuan Bio-Tech Co ROC (Joel Greenblatt) % Chart
Shandong Bailong Chuangyuan Bio-Tech Co Annual Data
SHSE:605016 vs KHC, GIS: ROC (Joel Greenblatt) % Comparison
For the Packaged Foods subindustry, Shandong Bailong Chuangyuan Bio-Tech Co's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Bailong Chuangyuan Bio-Tech Co ROC (Joel Greenblatt) % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Shandong Bailong Chuangyuan Bio-Tech Co's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Shandong Bailong Chuangyuan Bio-Tech Co's ROC (Joel Greenblatt) % falls into.
Shandong Bailong Chuangyuan Bio-Tech Co ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 35.17% mean?
Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) has a ROC (Joel Greenblatt) % of 35.17% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Shandong Bailong Chuangyuan Bio-Tech Co and its competitors. This is 39% above median its historical median of 25.31. Over the past decade, Shandong Bailong Chuangyuan Bio-Tech Co's ROC (Joel Greenblatt) % has ranged from 21.46 to 33.51. According to the industry distribution chart, Shandong Bailong Chuangyuan Bio-Tech Co ranks #350 out of 1979 companies in the Consumer Packaged Goods industry, placing it in the top 17.7%.
Is Shandong Bailong Chuangyuan Bio-Tech Co's ROC (Joel Greenblatt) % too high?
Shandong Bailong Chuangyuan Bio-Tech Co's current ROC (Joel Greenblatt) % of 35.17% is 39% above median its 10-year median of 25.31. Over the past 10 years, this metric has ranged from a low of 21.46 to a high of 33.51. The Consumer Packaged Goods industry median ROC (Joel Greenblatt) % is 12.05. Shandong Bailong Chuangyuan Bio-Tech Co's value of 35.17% is 191.9% above this industry median. Based on the distribution chart, Shandong Bailong Chuangyuan Bio-Tech Co ranks #350 out of 1979 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Shandong Bailong Chuangyuan Bio-Tech Co has a GF Score™ of 97/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Bailong Chuangyuan Bio-Tech Co's ROC (Joel Greenblatt) % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Shandong Bailong Chuangyuan Bio-Tech Co ranks #350 out of 1979 companies for ROC (Joel Greenblatt) %. This places Shandong Bailong Chuangyuan Bio-Tech Co in the top 18% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 12.05. Shandong Bailong Chuangyuan Bio-Tech Co's value of 35.17% is 191.9% above this benchmark. Historically, Shandong Bailong Chuangyuan Bio-Tech Co's own ROC (Joel Greenblatt) % has ranged from 21.46 to 33.51 over the past decade. While the company's 10-year median is 25.31 vs. the industry median of 12.05, Shandong Bailong Chuangyuan Bio-Tech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Consumer Packaged Goods company?
The median ROC (Joel Greenblatt) % among Consumer Packaged Goods companies is 12.05, based on 1,979 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Bailong Chuangyuan Bio-Tech Co's current ROC (Joel Greenblatt) % of 35.17% is 191.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Shandong Bailong Chuangyuan Bio-Tech Co and its competitors. For the Consumer Packaged Goods industry, the median ROC (Joel Greenblatt) % is 12.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Bailong Chuangyuan Bio-Tech Co's current ROC (Joel Greenblatt) % is 35.17%, which is 39% above median its own 10-year median of 25.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Bailong Chuangyuan Bio-Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥23.03, compared to a current price of ¥20.15 — trading 12.5% below its estimated fair value. The current ROC (Joel Greenblatt) % is 35.17%, which is 39% above median its 10-year median of 25.31 and 191.9% above the Consumer Packaged Goods industry median of 12.05. Shandong Bailong Chuangyuan Bio-Tech Co's overall GF Score™ is 97/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016), the current ROC (Joel Greenblatt) % is 35.17% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Bailong Chuangyuan Bio-Tech Co stock appears to be undervalued.
The current stock price of ¥20.15 is trading 12.5% below its estimated GF Value™ of ¥23.03.
GuruFocus considers Shandong Bailong Chuangyuan Bio-Tech Co to be Modestly Undervalued.
Key valuation signals for SHSE:605016:
ROC (Joel Greenblatt) %: 35.17% (39% above median its 10-year median of 25.31)
GF Value™: ¥23.03 vs. price of ¥20.15 (12.5% below fair value)
Industry Position: 191.9% above the Consumer Packaged Goods median (#350 of 1979)
No single metric tells the full story. See the SHSE:605016 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Bailong Chuangyuan Bio-Tech Co Ltd is engaged in the research and development, production and sales of prebiotic series products, dietary fiber series products, other starch sugar (alcohol) series products and healthy sweetener products.
97GF Score
Get the complete analysis for SHSE:605016
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:605016 has been successfully added to your 
